These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24867974)

  • 1. Decreased ceftriaxone susceptibility in emerging (35B and 6C) and persisting (19A) Streptococcus pneumoniae serotypes in the United States, 2011-2012: ceftaroline remains active in vitro among β-lactam agents.
    Mendes RE; Biek D; Critchley IA; Farrell DJ; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4923-7. PubMed ID: 24867974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
    Jacobs MR; Good CE; Windau AR; Bajaksouzian S; Biek D; Critchley IA; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2716-9. PubMed ID: 20308374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftaroline Activity Against Multidrug-Resistant Streptococcus pneumoniae from U.S. Medical Centers (2014) and Molecular Characterization of a Single Ceftaroline Nonsusceptible Isolate.
    Pfaller MA; Mendes RE; Flamm RK; Jones RN; Sader HS
    Microb Drug Resist; 2017 Jul; 23(5):571-579. PubMed ID: 27918694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.
    Richter SS; Diekema DJ; Heilmann KP; Dohrn CL; Riahi F; Doern GV
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6484-9. PubMed ID: 25136018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
    Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
    Sader HS; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2013 May; 76(1):61-8. PubMed ID: 23535208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftaroline activity against bacterial pathogens frequently isolated in U.S. medical centers: results from five years of the AWARE surveillance program.
    Sader HS; Flamm RK; Streit JM; Farrell DJ; Jones RN
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2458-61. PubMed ID: 25645844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
    Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN
    Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine.
    Jacobs MR; Good CE; Bajaksouzian S; Windau AR
    Clin Infect Dis; 2008 Dec; 47(11):1388-95. PubMed ID: 18959493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998-2011).
    Jones RN; Sader HS; Mendes RE; Flamm RK
    Diagn Microbiol Infect Dis; 2013 Jan; 75(1):107-9. PubMed ID: 23009730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Activity of Ceftaroline and Comparator Agents Against Ceftriaxone-Nonsusceptible
    Sader HS; Castanheira M; Carvalhaes CG; Arends SJR; Mendes RE
    Microb Drug Resist; 2022 Sep; 28(9):935-940. PubMed ID: 35976086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
    Pfaller MA; Farrell DJ; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010.
    Tsai HY; Chen YH; Liao CH; Lu PL; Huang CH; Lu CT; Chuang YC; Tsao SM; Chen YS; Liu YC; Chen WY; Jang TN; Lin HC; Chen CM; Shi ZY; Pan SC; Yang JL; Kung HC; Liu CE; Cheng YJ; Liu JW; Sun W; Wang LS; Ko WC; Yu KW; Chiang PC; Lee MH; Lee CM; Hsu GJ; Hsueh PR
    Int J Antimicrob Agents; 2013 Oct; 42(4):312-6. PubMed ID: 23849332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009.
    Green MC; Mason EO; Kaplan SL; Lamberth LB; Stovall SH; Givner LB; Bradley JS; Tan TQ; Barson WJ; Hoffman JA; Lin PL; Hulten KG
    J Clin Microbiol; 2011 Jun; 49(6):2097-101. PubMed ID: 21450963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
    Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro synergy of penicillin, ceftriaxone and levofloxacin against serotype 19A Streptococcus pneumoniae.
    Tsai HY; Liao CH; Liu CY; Huang YT; Hsueh PR
    Int J Antimicrob Agents; 2015 Dec; 46(6):722-5. PubMed ID: 26453149
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimicrobial activity of ceftaroline tested against drug-resistant subsets of Streptococcus pneumoniae from U.S. medical centers.
    Flamm RK; Sader HS; Farrell DJ; Jones RN
    Antimicrob Agents Chemother; 2014; 58(4):2468-71. PubMed ID: 24514082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and molecular characterization of invasive isolates of Streptococcus pneumoniae serotypes 6C and 6D in Colombia.
    Parra EL; Duarte C; Rodríguez K; Sanabria O; Moreno J
    Enferm Infecc Microbiol Clin; 2017 May; 35(5):283-286. PubMed ID: 26971625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of recently collected Spanish pneumococci nonsusceptible to oral penicillin from serotypes not included in the 7-valent conjugate vaccine.
    Fenoll A; Aguilar L; Giménez MJ; Vicioso MD; Robledo O; Granizo JJ; Coronel P
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2696-8. PubMed ID: 20308373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997.
    Wald ER; Mason EO; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2001 Jan; 20(1):34-9. PubMed ID: 11176564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.